Healthcare IT Today
JANUARY 31, 2024
As we see price transparency legislation take shape through 2027 and beyond, Turquoise accelerates support for healthcare organizations as they embed transparency and simplicity at every step in the transaction,” says Turquoise CEO, Chris Severn. Learn more at turquoise.health.
Health Populi
MAY 4, 2023
Reviewing the annual 2023 report from the IQVIA Institute for Human Data Science discussing The Use of Medicines in the U.S. It’s a volume speaking volumes on the current picture of prescribed meds, spending and revenues, health care utilization trends, and a forecast looking out to 2027.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Henry Kotula
JULY 1, 2019
Between 2020 and 2027, retail drug spending under private health insurance is projected to increase at a rate of 3 percent to 6 percent a year as the impact of generics on spending plateaus, biosimilars continue to see slow uptake, and costly new therapies enter the market. WHAT’S THE IMPACT. One is that drug spending will grow faster.
Health Populi
OCTOBER 8, 2019
The Centers for Medicare and Medicaid Services (CMS) forecasts that prescription drug spending will be the fastest-growing cause of rising health spending by 2027. Pricing failure, the second big waste factor, is predominantly challenged by pharmaceutical/prescription drug pricing based on this research.
Expert insights. Personalized for you.
97 
Let's personalize your content